Certified by Founder Lodge
Proniras Corporation
United States - Seattle, Washington
START UP
1 Disclosed Funding Rounds $4,650,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Proniras Corporation is a clinical-stage biotechnology developing novel small-molecule therapeutics for the treatment of substance use and specialty central nervous system disorders. The Comp
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 02 ,2024 | Series B | $4,650,000 |
Accelerator Life Science Partners
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Tutor | $34,000,000 | (Dec 2, 2025)
Jeeva AI | $9,000,000 | (Dec 2, 2025)
Clipbook | $3,300,000 | (Dec 2, 2025)
Raindrop | $15,000,000 | (Dec 2, 2025)
Mixx Technologies Inc | $33,000,000 | (Dec 2, 2025)
